Luna Adhikari

Dr. Luna Adhikari


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2025 in International Journal of Research in Medical Sciences
Verified
Journal Article
Open access
PDF file
ASApurba Sarkar
Apurba Sarkar
LALuna Adhikari
Luna Adhikari
TMTapan Majumdar
Tapan Majumdar
RSRekha Sharma
Rekha Sharma
In India, the prevalence of hepatitis C virus (HCV) infection ranges from 0.5% to 1.5%, with most infected individuals being asymptomatic and without jaundice. HCV is responsible for approximately 25% of liver-related disorders, including hepatocellular carcinoma (HCC) and liver cirrhosis, and is increasingly recognized as a cause of chronic liver diseases. Populations at high risk for HCV transmission include intravenous drug users (IDUs), renal transplant recipients, dialysis patients, and those receiving blood products. HCV is categorized into seven genotypes, each with various sub-genotypes, playing a crucial role in epidemiology and outbreak investigations. An extensive literature search was conducted in Scopus, PubMed, and Web of Science from January 2003 to December 2023, using keywords such as ‘hepatitis C’ and ‘genotype’ along with MeSH terms for refinement. Out of 739 retrieved articles, 20 articles fulfilled the inclusion criteria for analysis, with the mean age of participants being 41±4. A statistically significant difference (p<0.001) was found between gender and sample size. Notably, genotype 3 was most prevalent (45%), while genotype 1 and 3 showed equal prevalence (26%) in the North-Eastern region. It is essential to implement and monitor government initiatives like NVHCP to enhance understanding and public health regarding HCV.

3 February 2026 in Infectious Disease Reports
Verified
Journal Article
Open access
PDF file
SPSaurav Patgiri
Saurav Patgiri
ASANUKALPA Saikia
ANUKALPA Saikia
SYSushmita Yadav
Sushmita Yadav
MAMd Atique Ahmed
Md Atique Ahmed
LALuna Adhikari
Luna Adhikari
HKHarpreet Kaur
Harpreet Kaur
Background: Melioidosis, caused by Burkholderia pseudomallei, is a severe and often underdiagnosed infection endemic to South Asia, Southeast Asia, and northern Australia. While pneumonia and sepsis are the classical presentations, the disease is increasingly recognized for its diverse and atypical clinical manifestations. Objective: The objective is to improve diagnostic accuracy and increase clinical awareness in both endemic and non-endemic settings by reviewing and classifying atypical presentations of melioidosis that have been documented in the literature. Methods: A narrative, case-based review was conducted using 238 published case reports and series from endemic and transitional regions during the period from 2000 to 2025. Cases with non-respiratory presentations or anatomical locations not commonly linked to melioidosis were classified as atypical. Clinical syndromes were used to classify the extracted cases, and common patterns in presentation, diagnosis, and outcome were examined. Results: One hundred and sixty published articles were included after a full text review. The most frequent atypical presentations included neurological involvement (e.g., brain abscess, encephalomyelitis), musculoskeletal infections (osteomyelitis, myositis), thyroid abscess, tubo-ovarian abscess, and dermatologic manifestations such as erythema nodosum. Imported and pediatric cases were also found. Numerous cases were misidentified as cancer, fungal infections, or tuberculosis. Among risk factors, diabetes mellitus was the most prevalent. Non-specific symptoms, a lack of laboratory capacity, and incorrect pathogen identification frequently resulted in delays in diagnosis. Conclusions: In endemic areas, melioidosis should be taken into account when making a differential diagnosis of a variety of clinical syndromes, especially in patients who have diabetes or have had relevant environmental exposure. Poor outcomes and diagnostic delays are greatly exacerbated by atypical presentations. Improving diagnostic capabilities and raising awareness are crucial to lessening the worldwide burden of this often ignored but potentially deadly infection.